Machine Learning

Anyline's TireBuddy uses smartphone AI to create objective tire reports, promising a new era of transparency and efficiency for dealers and car owners.

A new partnership in Southern California uses predictive AI to spot grid failures before they happen, aiming to prevent catastrophic wildfires and power outages.

With new CTO Sharath Pasupunuti, Sidecar Health doubles down on its AI strategy to empower consumers and challenge the traditional health insurance model.

Ever.Ag's Feedlot IQ, an AI-powered platform, aims to revolutionize cattle management by unifying data for earlier health detection and improved efficiency.

Gartner recognizes ETQ for its visionary QMS platform as the industry tackles supply chain risks and embraces data-driven, automated quality management.

Following a new White House mandate, Voyager Technologies is building the core infrastructure for a permanent lunar base, blending commerce and national security.

BlackSky's new deal validates its high-tech satellite intel, proving its model for turning trials into major contracts in the competitive space-tech market.

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

With a new veteran advisor, SpinLaunch pivots to commercialize its Meridian LEO network, aiming for a 'sovereign' niche in the competitive satellite market.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

New multi-year data for Fabry and Pompe disease therapies from Amicus Therapeutics showcases sustained benefits, offering new hope for long-term patient outcomes.

A legacy manufacturer turned decades of dormant engineering files into a strategic asset, recovering 600 hours and boosting efficiency by 98% with AI.

Amidst staggering growth, Tidal Cyber's success signals a pivotal industry move from reactive alerts to proactive, adversary-focused cybersecurity.

A new partnership aims to slash waste and streamline clinical trials, heralding a tech-driven transformation in the backbone of drug development.

Cyber threat intelligence firm Intel 471 elevates CINO Michael DeBolt to President, signaling a strategy to embed deep operational expertise into its core.

Relay Therapeutics' experimental drug, zovegalisib, offers new hope for a common and hard-to-treat form of advanced breast cancer with a promising safety profile.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.